Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment. Predictors of Sustained Complete Response After Neoadjuvant Chemo/Radiotherapy for Locally Advanced Rectal Cancer

NCT04917263 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.

NCT NCT04917263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04917263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment. Predictors of Sustained Complete Response After Neoadjuvant Chemo/Radiotherapy for Locally Advanced Rectal Cancer
Lead sponsor
University of Padova
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 31, 2024
Enrollment
544 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer